Core Insights - Rippling, an HR software startup, raised $450 million in Series G funding, achieving a valuation of $16.8 billion, focusing on global revenue growth over immediate profitability [1][4][5] Funding and Valuation - The funding round included participation from notable investors such as Y Combinator, Elad Gil, Sands Capital, GIC, and Goldman Sachs Growth [2] - The new valuation of $16.8 billion marks an increase from the previous valuation of $13.5 billion in early 2024 [4] Employee Equity and IPO Plans - Rippling plans to repurchase up to $200 million of equity from current and former employees through a tender offer, which may become an annual event [2][3] - The CEO stated that the company does not have immediate plans for an IPO, emphasizing the need for profitability before considering going public [4][6] Business Performance and Strategy - Rippling has surpassed $100 million in annual recurring revenue and serves over 20,000 customers with a suite of more than 20 products [5] - The company is prioritizing growth over profitability, indicating a strategic choice to expand rapidly rather than slow down for immediate profit [6] Legal Challenges - Rippling is involved in ongoing legal disputes with competitor Deel, including allegations of corporate espionage, which have raised questions about competitive practices in the tech industry [7][8]

Core Insights - MP Materials is strategically moving downstream into high-value rare earth magnet manufacturing, with its Fort Worth, TX facility serving as the production hub and engineering headquarters [1] Group 1: Facility Development and Operations - Construction of the Independence Facility began in February 2022, marking the first fully integrated rare earth metal, alloy, and magnet manufacturing operation in the U.S. [2] - The facility converts NdPr oxide from Mountain Pass into permanent magnets and precursor products, with integrated capabilities for magnet recycling [2] - In 2024, the company commissioned electrowinning capabilities to produce NdPr metal and added strip casting capabilities in 2025 for NdFeB alloy flake production [3] Group 2: Revenue Generation and Financial Performance - The Magnetics segment began generating revenues in Q1 2025, with $5.2 million from sales to General Motors, contributing $493 million to segment adjusted EBITDA [4] - Quarterly revenues increased to $19.9 million in Q2, $21.9 million in Q3, and $19.9 million in Q4 of 2025 [4] - For the full year 2025, the Magnetics segment generated $66.9 million in revenues, accounting for approximately 30% of total company revenues, and delivered $26.4 million in adjusted EBITDA [5] Group 3: Strategic Partnerships and Future Plans - In July 2025, MP Materials entered a long-term supply agreement with Apple for magnet development and recycling capabilities [6] - The company is expanding the Independence Facility's annual capacity to 3,000 MTs and plans to construct the 10X Facility, expected to produce 7,000 MTs annually starting in 2028 [7] - These efforts will increase overall U.S. rare earth magnet production capacity to an estimated 10,000 MTs per year, enhancing supply-chain resilience [8] Group 4: Market Performance and Valuation - MP Materials' shares have increased by 125.8% over the past year, outperforming the industry's growth of 58.5% [9] - The Magnetics segment's revenues in 2025 were $66.9 million, representing about 30% of total sales, with long-term supply agreements secured with General Motors and Apple [10] - The Zacks Consensus Estimate for MP Materials' 2026 earnings is 19 cents per share, improving from a loss of 24 cents in 2025, with a projected estimate of $1.12 per share for 2027 [11]

Core Viewpoint - Cheniere Energy, Inc. is recognized as a leading investment opportunity in the infrastructure sector, despite a recent price target reduction by JPMorgan, which still indicates significant upside potential for the stock [1][2]. Financial Performance and Guidance - Cheniere Energy is the largest producer of liquefied natural gas (LNG) in the U.S. and the second-largest globally [2]. - JPMorgan has lowered its price target for Cheniere from $338 to $325, maintaining an 'Overweight' rating, which suggests over 25% upside potential from the current share price [2]. - The company is expected to perform well in its upcoming Q1 report, with analysts predicting it will exceed its FY 2026 guidance due to favorable spreads [3]. - For FY 2026, Cheniere targets a consolidated adjusted EBITDA of $6.75 billion to $7.25 billion, compared to $6.94 billion achieved in the previous year [4]. - The expected distributable cash flow for FY 2026 is projected to be between $4.35 billion and $4.85 billion, down from $5.3 billion in 2025, reflecting higher production but lower spot margins [4]. - Spot margins have recently surged due to supply disruptions related to the US-Iran war, which may positively impact the company's financial outlook [4]. Market Position and Comparisons - Cheniere Energy has been included in lists of the best infrastructure and natural gas stocks to buy, indicating strong market positioning [1][5]. - While LNG is recognized as a valuable investment, there are suggestions that certain AI stocks may offer greater upside potential with less risk [5].

Core Viewpoint - Geopolitical tensions have driven WTI crude oil prices above $114 per barrel, yet oil producers are not capturing the expected financial benefits due to hedging, debt burdens, and margin compression, resulting in muted earnings growth for the SPDR S&P Oil & Gas Exploration & Production ETF (XOP) which has only gained approximately 30% year-to-date despite the oil price surge [1][4]. Group 1: Performance of XOP - XOP has delivered only a ~30% gain year-to-date, significantly lower than the oil price increase, as hedging programs and debt repayments have absorbed potential earnings [1][4]. - The fund's equal-weight structure exposes it to smaller, more leveraged drillers, which can negatively impact overall performance when these companies struggle [2][5]. - XOP is best suited for short-duration tactical investments during oil shocks rather than as a core energy holding, due to ongoing capital expenditure requirements and OPEC's supply responses limiting real returns [3][12]. Group 2: Structural Constraints - XOP's equal-weight methodology leads to a drag on performance as smaller, more leveraged companies are weighted equally with larger operators, which can pull down the entire fund during downturns [14]. - Continuous capital expenditures are necessary for E&P companies to maintain production levels, with ConocoPhillips spending $12.6 billion in 2025 and Occidental Petroleum spending $6.4 billion, limiting free cash flow available for shareholders [14]. - OPEC's response to price spikes, including announced output increases, adds bearish pressure on oil prices, with current predictions indicating a low probability of WTI reaching $110 in the near term [14]. Group 3: Comparison with Refiners - XOP's exposure to refiners is minimal, with Marathon Petroleum representing only ~2.5% of the fund, while it has significantly outperformed XOP with a 38% gain year-to-date compared to XOP's 30% [9]. - Refining margins for Marathon Petroleum expanded from $12.9 to $18.7 per barrel, contributing to its strong performance, which XOP investors have largely missed out on [9]. - Integrated majors like Chevron have also faced challenges, with a 30% decline in net income despite record production, highlighting the difficulties faced by pure-play E&P companies that dominate XOP's holdings [10].

Sign in Sign in to access your portfolio ...

Core Insights - Mr Mikes Restaurants has signed a development agreement for five new restaurants in Ontario, Canada, as part of its ongoing expansion strategy [1][5] - The agreement was made with a well-established multi-unit restaurant operator, indicating confidence in the brand's growth potential [1][2] - The company aims to reach a target of 100 locations nationwide, currently operating 50 restaurants across various provinces [4][5] Expansion Strategy - The five-store agreement is seen as a significant milestone for Mr Mikes as it expands deeper into Ontario and prepares for further growth in Atlantic Canada [2][3] - Site selection in Ontario is already underway, reflecting the brand's proactive approach to expansion [3] Franchise Support Framework - Mr Mikes emphasizes its franchise support framework, which includes recruitment, site selection guidance, operational training, marketing assistance, and ongoing business development services [3][4] - The company believes that the commitment from seasoned operators to multi-location deals demonstrates the scalability and sustainability of the Mr Mikes model [4]

Core Viewpoint - The VanEck BDC Income ETF (BIZD) aims to provide income through a diversified portfolio of Business Development Companies (BDCs), but the current dividend safety across its top holdings is inconsistent, warranting careful evaluation before assuming the sustainability of its yield [1][6]. Group 1: Income Generation Mechanism - BDCs are specialized lenders that provide credit to middle-market companies unable to access public debt markets, and they are required by law to distribute at least 90% of taxable income to shareholders, resulting in high yields [2]. - BIZD collects dividends from over 25 individual BDCs, with Ares Capital being the largest holding at 13.1%, followed by Blue Owl Capital Corp at 7.9%, Main Street Capital at 6.7%, Golub Capital BDC at 2.9%, and FS KKR Capital at 2.7% [2]. Group 2: Impact of Federal Reserve Rates - The income generated by BDCs is primarily floating-rate, meaning that when the Federal Reserve cuts rates, portfolio yields decrease. The Fed has reduced rates three times since September 2025, lowering the federal funds rate from 4.5% to 3.75%, which poses a significant challenge for BIZD's holdings [3]. Group 3: Performance of Key Holdings - Ares Capital is the most critical position in BIZD, maintaining a core EPS of $0.50 per share throughout 2025, which comfortably covers its $0.48 quarterly dividend. Net investment income per share ranged from $0.48 to $0.54, although weighted average portfolio yields fell from 11.1% to 10.3% [4]. - Despite Ares Capital's stability, two major holdings in BIZD have already cut their dividends in 2026, indicating uneven dividend safety across the portfolio [6].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Aquestive Therapeutics, Inc. during the specified class period of the upcoming lead plaintiff deadline on May 4, 2026 [1]. Group 1: Class Action Details - Investors who bought Aquestive securities between June 16, 2025, and January 8, 2026, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3][6]. - The lawsuit alleges that the defendants made false or misleading statements regarding the New Drug Application for Anaphylm and concealed significant human factors related to its sublingual film [5]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms issuing notices may lack the necessary experience [4]. - Rosen Law Firm has a strong history in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its performance in securities class action settlements, ranking highly in the industry since 2013 [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Aldeyra Therapeutics, Inc. securities between November 3, 2023, and March 16, 2026, of the May 29, 2026, deadline to become a lead plaintiff in a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Aldeyra securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by visiting the provided link or contacting the firm directly [3][6]. - The deadline to move the Court to serve as lead plaintiff is May 29, 2026, and a lead plaintiff acts on behalf of other class members [3]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [4]. Group 3: Case Allegations - The lawsuit alleges that defendants made false and misleading statements regarding the clinical trials of reproxalap, an Aldeyra drug candidate, leading to unreliable positive findings [5]. - It is claimed that the inconsistency of trial results rendered the defendants' statements about Aldeyra's business and prospects materially false and misleading [5]. - The lawsuit asserts that when the true details were revealed, investors suffered damages as a result [5].

Core Viewpoint - Broadcom's extended partnership with Alphabet for Tensor Processing Units (TPUs) significantly enhances its growth outlook and alleviates previous bearish concerns regarding its stock [1][2]. Partnership Details - The renewed agreement between Broadcom and Alphabet solidifies their long-standing collaboration on TPUs, which has been a major growth driver for both companies [2][4]. - Concerns that Alphabet might shift TPU production in-house or to a cheaper vendor have been mitigated by this deal, as Broadcom's ASIC platform is comprehensive and sticky [4]. Growth Potential - The partnership expansion includes a collaboration with Anthropic, granting access to 3.5 gigawatts of TPUs starting in 2027, with a $21 billion order for TPUs from Anthropic this year [5]. - Broadcom previously projected $100 billion in custom AI chip revenue by fiscal 2027, and this announcement suggests that this estimate may be conservative [7]. Financial Metrics - Broadcom's TPU sales are expected to maintain gross margins similar to its semiconductor business, further supporting its growth narrative [7]. - The company is gaining new ASIC customers, including OpenAI, which indicates a shift away from reliance on Nvidia's GPUs [7]. Investment Outlook - With the two major bearish arguments—lower margins and potential loss of TPU business—debunked, Broadcom is positioned as a strong growth stock [8].